Author/Authors :
Amasyalı, Elvan Malazgirt Devlet Hastanesi - İç Hastalıkları Kliniği, Turkey , Kılıçlı, Fatih Cumhuriyet Üniversitesi - Tıp Fakültesi - Endokrinoloji ve Metabolizma Bilim Dalı, Turkey , Acıbucu, Fettah Cumhuriyet Üniversitesi - Tıp Fakültesi - Endokrinoloji ve Metabolizma Bilim Dalı, Turkey , Say, Ramazan Elbistan Devlet Hastanesi - Hastalıkları Kliniği, Turkey , Uygungelen, Bülent Andırın Devlet Hastanesi - Hastalıkları Kliniği, Turkey , Arslan, Mübeccel
Abstract :
Aim. Our aim was to investigate the relationship between hs-CRP and non-alcoholic fatty liver disease with metabolic syndrome patients; that gradually gained importance. Methods. The study included 60 metabolic syndrome patients (26 males, 34 females) and 42 healthy individuals (21 male, 21 female). Results. As a result we found that the frequency of hepatosteatosis in our metabolic syndrome patients was found as 78.3%, hs-CRP levels were significantly elevated in these patients and this elevation showed a positive correlation with the grade of hepatosteatosis. Conclusion. Elevated hs-CRP shows progression to hepatosteatosis in patients with metabolic syndrome
NaturalLanguageKeyword :
Metabolic syndrome , hepatosteatosis , hs , CRP